Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Cancer Investigation
|
August 31, 2006
New agents for intrathecal administration
Stacie Stapleton, Susan Blaney
Pediatric Blood & Cancer
|
June 19, 2008
Valacyclovir and acyclovir pharmacokinetics in immunocompromised children
Lisa Bomgaars, Patrick Thompson, Stacey Berg, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2003
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates
Jamie Renbarger, Alexander Aleksic, Leticia McGuffey, et al.
Journal of Pediatric Hematology/Oncology
|
July 9, 2003
Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study
Robert J Hayashi, Susan Blaney, Jim Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study
Kathleen Neville, Susan Blaney, Mark Bernstein, et al.
Anti-Cancer Drugs
|
October 1, 2004
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines
Linna Zhang, Sharon E Plon, Jed G Nuchtern, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
January 31, 2015
Teledermatology as an educational tool for teaching dermatology to residents and medical students
Lindsay N Boyers, Amanda Schultz, Rasa Baceviciene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study
Neyssa M Marina, Debon Cochrane, Elaine Harney, et al.
Journal of Pediatric Hematology/Oncology
|
July 9, 2003
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study
Anne-Marie Langevin, Steven D Weitman, John G Kuhn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2005
A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study
Loretta Lau, Jeffery G Supko, Susan Blaney, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Cancer Investigation
|
August 31, 2006
New agents for intrathecal administration
Stacie Stapleton, Susan Blaney
Pediatric Blood & Cancer
|
June 19, 2008
Valacyclovir and acyclovir pharmacokinetics in immunocompromised children
Lisa Bomgaars, Patrick Thompson, Stacey Berg, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2003
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates
Jamie Renbarger, Alexander Aleksic, Leticia McGuffey, et al.
Journal of Pediatric Hematology/Oncology
|
July 9, 2003
Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study
Robert J Hayashi, Susan Blaney, Jim Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study
Kathleen Neville, Susan Blaney, Mark Bernstein, et al.
Anti-Cancer Drugs
|
October 1, 2004
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines
Linna Zhang, Sharon E Plon, Jed G Nuchtern, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
January 31, 2015
Teledermatology as an educational tool for teaching dermatology to residents and medical students
Lindsay N Boyers, Amanda Schultz, Rasa Baceviciene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study
Neyssa M Marina, Debon Cochrane, Elaine Harney, et al.
Journal of Pediatric Hematology/Oncology
|
July 9, 2003
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study
Anne-Marie Langevin, Steven D Weitman, John G Kuhn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2005
A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study
Loretta Lau, Jeffery G Supko, Susan Blaney, et al.
Page
of 3